Keywords: Blood Vessels, Neurodegeneration, cerebral small vessel disease, iron deposition, quantitative susceptibility mapping, cognitive function
Motivation: To explore iron metabolism biomarkers associated with cognitive dysfunction in patients with CSVD, addressing the need for reliable diagnostic indicators.
Goal(s): To quantify iron deposition in deep nuclei with quantitative susceptibility mapping and to evaluate its relationship with cognitive dysfunction
Approach: Applied quantitative susceptibility mapping to assess iron deposition in deep nuclei, and utilized statistical analyses including ANOVA, Bonferroni correction, and Spearman's correlation to evaluate the relationship between susceptibility values and cognitive performance as measured by MoCA scores
Results: Iron deposition in the right putamen may serve as a biomarker for cognitive dysfunction in CSVD
Impact: It demonstrates the association between iron deposition in deep nuclei and cognitive dysfunction in CSVD, providing evidence for iron deposition in specific regions as a diagnostic marker and insight into the mechanisms of cognitive dysfunction, which guide future therapeutic strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords